A phase I trial of BGC 201531 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 30 May 2010
At a glance
- Drugs AP 1531 (Primary)
- Indications Inflammation; Migraine; Neurogenic pain
- Focus Adverse reactions; Therapeutic Use
- 19 May 2008 Phase II trial planned to start in the first half of 2009 according to BTG media relase.
- 02 Apr 2008 Results are expected in the second half of 2008.
- 02 Apr 2008 Dosing of the second cohort has commenced, according to a BTG media release.